Shattuck Labs Inc
STTK
NASDAQ
Biotechnology
$7.42
USD
+0.10 (+1.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $661.53M
Volume 640.7K
Price Target
$17.00 – $18.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $18.00 and a min estimate of $17.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$17.67
+$5.7 vs prior
Implied Upside
+138.1%
+76.4% vs prior
Analyst Covering
3
Unchanged vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0.3300 Gap
Median $18.00 vs avg $17.67 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Yigal Nochomovitz | Citigroup | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Joseph Pantginis | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Joseph Stringer | Needham | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GYRE
Gyre Therapeutics Inc
$6.68
▲ +2.1%
MNPR
Monopar Therapeutics Inc
$113.04
▲ +2.4%
NGNE
Neurogene Inc
$36.14
▲ +1.4%
ACHV
Achieve Life Sciences Inc
$7.59
▲ +4.7%
BBOT
BridgeBio Oncology Therapeutics Inc
$9.06
▼ -1.8%
RIGL
Rigel Pharmaceuticals Inc
$42.58
▲ +4.4%
CTMX
CytomX Therapeutics Inc
$3.36
▲ +0.3%
IMMX
Immix Biopharma Inc
$10.97
▲ +0.5%